CMS Should Do More To Fulfill The IRA’s Promise To Lower Drug Costs For Patients

The Food and Drug Administration on Monday approved a blood test to detect colorectal cancer in individuals age 45 and older, adding another screening option for the second-most common cause of U.S. cancer deaths.

By |2024-08-14T09:39:18-04:00August 14th, 2024|Latest News|0 Comments

Wells Fargo and J&J lawsuits: Key legal insights for fiduciaries and benefits advisors

The Food and Drug Administration on Monday approved a blood test to detect colorectal cancer in individuals age 45 and older, adding another screening option for the second-most common cause of U.S. cancer deaths.

By |2024-08-14T09:38:37-04:00August 14th, 2024|Latest News|0 Comments

What to watch when Medicare releases first negotiated drug prices

The Food and Drug Administration on Monday approved a blood test to detect colorectal cancer in individuals age 45 and older, adding another screening option for the second-most common cause of U.S. cancer deaths.

By |2024-08-14T09:37:56-04:00August 14th, 2024|Latest News|0 Comments

TRICARE becomes part of fight over pharmacy benefit managers

The Food and Drug Administration on Monday approved a blood test to detect colorectal cancer in individuals age 45 and older, adding another screening option for the second-most common cause of U.S. cancer deaths.

By |2024-08-14T09:36:23-04:00August 14th, 2024|Latest News|0 Comments

Driving Value-Based Payment Reform Through the Community Oncology Lens

The Food and Drug Administration on Monday approved a blood test to detect colorectal cancer in individuals age 45 and older, adding another screening option for the second-most common cause of U.S. cancer deaths.

By |2024-08-13T09:31:44-04:00August 13th, 2024|Latest News|0 Comments

Q&A: Unveiling the Current State of PBMs’ Role in Independent Pharmacy

The Food and Drug Administration on Monday approved a blood test to detect colorectal cancer in individuals age 45 and older, adding another screening option for the second-most common cause of U.S. cancer deaths.

By |2024-08-13T09:30:27-04:00August 13th, 2024|Latest News|0 Comments

Are Changes To The Medicare Physician Fee Schedule Driving Value In US Health Care?

The Food and Drug Administration on Monday approved a blood test to detect colorectal cancer in individuals age 45 and older, adding another screening option for the second-most common cause of U.S. cancer deaths.

By |2024-08-13T09:28:19-04:00August 13th, 2024|Latest News|0 Comments

The Risk Of Perpetuating Health Disparities Through Cost-Effectiveness Analyses

The Food and Drug Administration on Monday approved a blood test to detect colorectal cancer in individuals age 45 and older, adding another screening option for the second-most common cause of U.S. cancer deaths.

By |2024-08-13T09:27:26-04:00August 13th, 2024|Latest News|0 Comments

“Eye-Opening” Drug Pricing Analysis Has Big Oncology Implications, Says COA Director

The Food and Drug Administration on Monday approved a blood test to detect colorectal cancer in individuals age 45 and older, adding another screening option for the second-most common cause of U.S. cancer deaths.

By |2024-08-12T09:32:07-04:00August 12th, 2024|Latest News|0 Comments